RxDoctor Payments Data

Mona Shete, MD

Plastic Surgery within the Head & Neck · Bakersfield, CANPI 1265736607

Payments from drug & device makers

What this record shows

Medtronic accounts for 63.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $1,028 and has fallen 87.0% since, to $133 in 2025.

$1,916in general payments, 2019–2025

Across 47 payments — averaging $40.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Optinose US, Inc.$236
  • Intersect ENT, Inc.$136
  • Inspire Medical Systems, Inc.$123
  • Atos Medical Inc$69
  • Boston Scientific$33
  • plus $98 from 5 others

What the payments were for

  • Travel & lodging$83043%
  • Food & beverage$1,08657%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)18$1,222
Optinose US, Inc.18$236
Intersect ENT, Inc.1$136
Inspire Medical Systems, Inc.2$123
Atos Medical Inc1$69
Boston Scientific2$33
Teleflex LLC1$23
Acclarent, Inc1$23
Stryker1$20
Smith+Nephew1$17
Merck1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,916 in reported general payments places this provider in the 65th percentile of 119 plastic surgery within the head & neck providers in California.

See all plastic surgery within the head & neck providers in California

Medicare billing

Part B allowed, 2024
$96,976
Medicare patients
254
Services billed
692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth18$1,616
Fluticasone Propionate105$914
Azelastine Hcl45$775
Ipratropium Bromide31$685
Levocetirizine Dihydrochloride61$379
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav42$249
Pantoprazole Sodium31$244
Famotidine28$214
Mupirocin28$194
Nystatin12$133
Methylprednisolone20$127
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$102
Cephalexin12$44
Prednisone11$25

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Bakersfield

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →